首页> 外文期刊>Acta medica Okayama >Contrast-enhanced Computed Tomography-Guided Percutaneous Cryoablation of Renal Cell Carcinoma in a Renal Allograft: First Case in Asia
【24h】

Contrast-enhanced Computed Tomography-Guided Percutaneous Cryoablation of Renal Cell Carcinoma in a Renal Allograft: First Case in Asia

机译:肾脏同种异体移植中造影剂增强的CT引导下经皮低温冷冻切除肾细胞癌:亚​​洲首例

获取原文
           

摘要

Nephron-sparing treatment should be offered whenever possible to avoid dialysis in allograph cases. Cryoablation is a new treatment option for treating small-sized renal cell cancer (RCCs). We report a case of RCC arising in a kidney allograft treated by cryoablation. To our knowledge, this is the first case in Asia of RCC in a renal allograft treated using cryoablation. Contrast-enhanced CT-guided percutaneous renal needle biopsy and cryoablation were used to identify the RCC, which could not be identified by other techniques. The postoperative course was uneventful. Contrast-enhanced CT also showed no recurrence or metastases at the 6-month follow-up.
机译:应尽可能采用保留肾单位的治疗方法,以避免在Allograph病例中进行透析。冷冻消融是治疗小规模肾细胞癌(RCC)的新治疗选择。我们报告一例经冷冻消融治疗的肾脏同种异体肾癌发生。据我们所知,这是亚洲首例使用冷冻消融治疗的肾同种异体肾癌。对比增强CT引导的经皮肾穿刺活检和冷冻消融术可鉴别RCC,而其他技术则无法鉴别。术后过程很顺利。对比增强的CT在6个月的随访中也没有发现复发或转移。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号